Drug
Terbinafine clinical trials
Also written Lamisil and MOB015B.
- studies test it
- 44
- open now
- 7
- in phase 3
- 14
- first study started
- 2002
Keep track of what changes. Save the Terbinafine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
43 studies that test it; most in 2004 (6)
| Year | Studies |
|---|---|
| 2002 | 4 |
| 2004 | 6 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 14
- Phase 2
- 12
- Phase 3
- 14
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 30 · Other 14
Moberg Pharma AB (7) · Novartis (4) · Novartis Pharmaceuticals (3) · Assiut University (3) · Teva Pharmaceuticals USA (2) · Mylan Pharmaceuticals Inc (2) · Roxane Laboratories (2) · Celtic Pharma Development Services (2)
Often tested with
Tested in the same studies.
Itraconazole (5) · Metronidazole (1) · Doxycycline (1) · Platelet rich plasma (1) · Butenafine (1) · Isotretinoin (1)
Studies
Open first, then newest update. How each study uses Terbinafine is read from its arms, and is right about nine times in ten.
Testing it · 44
- Terbinafine for CSA-AKI PreventionNot yet recruitingPhase 2Guangdong Provincial People's HospitalNCT07738328Written as Terbinafine
- Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)RecruitingPhase 2Swiss Cancer InstituteNCT07365423Written as Terbinafine
- A Phase 2 Study to Assess the Effectiveness of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the ToenailsNot yet recruitingPhase 2Onyx AxiomNCT07382427Written as 2.4% Topical Terbinafine
- Terbinafine Hydrochloride for the Treatment of OtomycosisNot yet recruitingNot applicableAssiut UniversityNCT07152327Written as Terbinafine Hydrochloride Cream
- From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B PatientsRecruitingPhase 1/2Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT06295328Written as Terbinafine
- Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea CapitisNot yet recruitingPhase 1Assiut UniversityNCT06400056Written as Terbinafine
- Efficacy and Safety of Terbinafine and ItraconazoleNot yet recruitingPhase 2/3Dhaka Medical CollegeNCT05881980Written as Terbinafine Tablets
- Efficacy Comparison of Itraconazole Pulse Therapy and Terbinafine Therapy in Treatment of Tinea Capitis in Children.CompletedNot applicableMuhammad Aamir LatifNCT07068256Written as Terbinafine
- Terbinafine HCl 250 mg Tablet Under Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00833586Written as Terbinafine HCl 250mg tablets
- A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)Active, not recruitingPhase 3Moberg Pharma ABNCT05279846Written as MOB015B
- Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00648713Written as Terbinafine Hydrochloride Tablets 250 mg
- Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00647647Written as Terbinafine Hydrochloride Tablets 250 mg
- Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test DesignCompletedPhase 1Moberg Pharma ABNCT06369727Written as MOB015B
- Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test DesignCompletedPhase 1Moberg Pharma ABNCT06369675Written as MOB015B
- Terbinafine Treatment of Axial SpondyloarthropathyWithdrawnEarly Phase 1Oregon Health and Science UniversityNCT05119712Written as Terbinafine Tablets
- Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00833664Written as Terbinafine HCl 250mg tablets
- Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuous Oral Terbinafine Therapy for Treatment of OnychomycosisCompletedPhase 1Combined Military Hospital AbbottabadNCT05578950Written as terbinafine
- Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin.CompletedPhase 3Pak Emirates Military HospitalNCT04880980Written as Terbinafine Pill
- Efficacy of Intralesional PRP in Treatment of OnychomycosisStatus unknownPhase 3Sohag UniversityNCT05128916Written as Oral terbinafine
- Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative ColitisCompletedPhase 2Hamilton Health Sciences CorporationNCT02606032Written as Terbinafine
See all 44 studies that test Terbinafine →
Given in every arm · 1 — Terbinafine is usual care beside what is tested
As the comparator · 4 — what is tested is compared with Terbinafine
- Efficacy of Ultraviolet B Phototherapy in the Management of Resistant and Relapsing Tinea Corporis and Tinea CrurisNot yet recruitingNot applicableCairo UniversityNCT07242703Written as Itraconazole + terbinafine
- Three-Arm Trial of Novel Treatment for Tinea PedisCompletedPhase 2South End Skin CareNCT03135912Written as Terbinafine Hydrochloride
- A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED)CompletedPhase 2Merck Sharp & Dohme LLCNCT00491764Written as Terbinafine
- Resin vs. Amorolfine vs. Terbinafine Treatment in OnychomycosisCompletedPhase 4Helsinki University Central HospitalNCT01851590Written as Terbinafine
Codes
What other systems call Terbinafine · ClinicalTrials.gg INT006691
- MeSH (NLM) D000077291TerbinafineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) G7RIW8S0XPTERBINAFINEConfirmed FDA, NLM, Wikidata
- RxNorm 37801Confirmed FDA, Wikidata
- Wikidata Q415259terbinafineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C48019TerbinafineOne source FDA
- DrugBank DB00857One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077291 | Terbinafine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | G7RIW8S0XP | TERBINAFINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 37801 | — | Confirmed FDA, Wikidata |
| Wikidata | Q415259 | terbinafine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C48019 | Terbinafine | One source FDA |
| DrugBank | DB00857 | — | One source Wikidata |
Also registered as terbinafine hydrochloride (UNII 012C11ZU6G · RxNorm 235838) and terbinafine, (z)- (UNII S76S370M70).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.